NL130094C - - Google Patents

Info

Publication number
NL130094C
NL130094C NL130094DA NL130094C NL 130094 C NL130094 C NL 130094C NL 130094D A NL130094D A NL 130094DA NL 130094 C NL130094 C NL 130094C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Application granted granted Critical
Publication of NL130094C publication Critical patent/NL130094C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/24Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL130094D 1966-06-13 NL130094C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55687266A 1966-06-13 1966-06-13
US75537068A 1968-08-26 1968-08-26

Publications (1)

Publication Number Publication Date
NL130094C true NL130094C (fr) 1900-01-01

Family

ID=27071276

Family Applications (2)

Application Number Title Priority Date Filing Date
NL130094D NL130094C (fr) 1966-06-13
NL6708113A NL6708113A (fr) 1966-06-13 1967-06-09

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6708113A NL6708113A (fr) 1966-06-13 1967-06-09

Country Status (11)

Country Link
US (2) US3455941A (fr)
BE (1) BE699845A (fr)
CH (1) CH555845A (fr)
DE (1) DE1695638A1 (fr)
DK (1) DK127066B (fr)
ES (1) ES341733A1 (fr)
FR (1) FR6693M (fr)
GB (1) GB1167392A (fr)
IL (1) IL28125A (fr)
NL (2) NL6708113A (fr)
SE (1) SE325576B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856962A (en) * 1973-07-10 1974-12-24 R Alphin Anti-inflammatory agents
US3895021A (en) * 1973-09-04 1975-07-15 Smithkline Corp N-heterocyclic pulvinic acid amides
AU607735B2 (en) * 1987-05-07 1991-03-14 A.H. Robins Company, Incorporated Novel cyclic carbamate derivatives
US5086055A (en) * 1990-12-24 1992-02-04 A. H. Robins Company, Incorporated Series of 5-[-(4-aryl-1-piperazinyl)alkyl]-2-oxazolidinone derivatives useful in the treatment of allergic conditions
US5162322A (en) * 1991-03-06 1992-11-10 A. H. Robbins Company, Incorporated Method of treating anxiety with 5-[(4-aryl or heteroaryl-1-piperazinyl]alkyl)-2-oxazolidinones
EP0719264B1 (fr) * 1993-09-15 1997-12-29 Merck Sharp & Dohme Ltd. Derives d'imidazolone et d'oxazolone utilises comme antagonistes de la dopamine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2537854A (en) * 1949-07-08 1951-01-09 Hoffmann La Roche Tetrahydropyridines and method of manufacture
US3085093A (en) * 1961-09-25 1963-04-09 Warner Lambert Pharmaceutical 1, 6-bis(2, 2, 6, 6-tetramethylpiperidino)-2, 4-hexadiyne
DE1210874B (de) * 1961-12-14 1966-02-17 Degussa Verfahren zur Herstellung von Diarylaminoderivaten von Arylaminoalkanen

Also Published As

Publication number Publication date
NL6708113A (fr) 1967-12-14
ES341733A1 (es) 1968-07-01
IL28125A (en) 1972-07-26
US3455941A (en) 1969-07-15
DE1695638A1 (de) 1972-03-02
DK127066B (da) 1973-09-17
CH555845A (de) 1974-11-15
US3513236A (en) 1970-05-19
SE325576B (fr) 1970-07-06
GB1167392A (en) 1969-10-15
BE699845A (fr) 1967-11-16
FR6693M (fr) 1969-02-10

Similar Documents

Publication Publication Date Title
AT11472B (fr)
AT2597B (fr)
FR311826A (fr)
AT10924B (fr)
AT11620B (fr)
AT11438B (fr)
AT11810B (fr)
AT11897B (fr)
AT2365B (fr)
AT11502B (fr)
AT11483B (fr)
AT11474B (fr)
AT11473B (fr)
AT11591B (fr)
AT11470B (fr)
AT11612B (fr)
AT11407B (fr)
AT11345B (fr)
AT10935B (fr)
AT11687B (fr)
AT10847B (fr)
AT10920B (fr)
AT2518B (fr)
AT10871B (fr)
AT11708B (fr)